Indeed, Roncalli et al. [35] demonstrated that Shh gene therapy in combination with ADM3100-stimulated progenitor cell mobilization (ADM3100 is a pharmacological agent that mobilizes progenitor cells) reduced cardiac fibrosis and promoted the development of capillaries and SMC containing vessels after MI. Here, SHH is linked to myocardial infarction.